Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Feb-23 4:06 PM View:  | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 13-Feb-23 | Grant | 6,432 | -- | -- | 42% 15.42K to 21.85K | |
| 15-Feb-23 4:04 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 13-Feb-23 | Grant | 14,300 | -- | -- | 41% 34.84K to 49.13K | |
| 05-Jan-23 5:47 PM View: | Burleson Tess Director | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 1,440 | -- | -- | 112% 1.28K to 2.72K | |
| 05-Jan-23 6:06 PM View: | Hanish Arnold C Director | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 1,440 | -- | -- | 78% 1.85K to 3.29K | |
| 05-Jan-23 6:08 PM View: | McCreedy Bruce J Jr. Director | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 1,440 | -- | -- | 414% 0.35K to 1.79K | |
| 05-Jan-23 5:44 PM View: | McVicar William K. Director | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 1,440 | -- | -- | 102% 1.41K to 2.85K | |
| 05-Jan-23 5:35 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 8,000 | -- | -- | 108% 7.42K to 15.42K | |
| 05-Jan-23 5:33 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 20,000 | -- | -- | 135% 14.84K to 34.84K | |
| 05-Jan-23 6:12 PM View: | Lieber Jonathan I Director | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 1,440 | -- | -- | 96% 1.5K to 2.94K | |
| 05-Jan-23 6:03 PM View: | Lammers Paul Director | Flex Pharma, Inc. (SLRX) | 03-Jan-23 | Grant | 1,440 | -- | -- | 518% 0.28K to 1.72K | |
| 07-Nov-22 4:33 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 03-Nov-22 | Grant | 7,314 | $1.73 | $12,682.50 | 5% 148.32K to 155.63K | |
| 07-Nov-22 4:34 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 03-Nov-22 | Grant | 10,000 | $1.73 | $17,340.00 | 3% 303.57K to 313.57K | |
| 08-Jun-22 3:12 PM View: | Lieber Jonathan I Director | Flex Pharma, Inc. (SLRX) | 07-Jun-22 | Private Purchase | 37,500 | $0.19 | $7,016.25 | 100% 0 to 37.5K | |
| 08-Jun-22 3:14 PM View: | Burleson Tess Director | Flex Pharma, Inc. (SLRX) | 07-Jun-22 | Private Purchase | 27,700 | $0.18 | $4,986.00 | 637% 4.35K to 32.05K | |
| 07-Jun-22 4:33 PM View: | McVicar William K. Director | Flex Pharma, Inc. (SLRX) | 06-Jun-22 | Private Purchase | 26,553 | $0.19 | $4,999.93 | 100% 0 to 26.55K | |
| 06-Jun-22 8:33 PM View: | Hanish Arnold C Director | Flex Pharma, Inc. (SLRX) | 03-Jun-22 | Private Purchase | 28,000 | $0.18 | $5,152.00 | 153% 18.35K to 46.35K | |
| 31-May-22 5:13 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 31-May-22 | Private Purchase | 28,000 | $0.18 | $5,040.00 | 23% 120.32K to 148.32K | |
| 31-May-22 5:17 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 26-May-22 | Private Purchase | 22,000 | $0.18 | $3,997.20 | 3% 834.12K to 856.12K | |
| 31-May-22 5:17 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 26-May-22 | Purchase | 21,900 | $0.18 | $3,987.40 | 3% 856.12K to 878.02K | |
| 05-May-22 4:03 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 03-May-22 | Grant | 10,000 | $0.19 | $1,863.00 | 9% 110.32K to 120.32K | |
| 09-Mar-22 4:01 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 03-Mar-22 | Private Purchase | 139,488 | $0.39 | $54,539.80 | 127% 110.19K to 249.67K | |
| 09-Mar-22 4:03 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 03-Mar-22 | Private Purchase | 76,246 | $0.39 | $29,812.20 | 224% 34.07K to 110.32K | |
| 05-Nov-21 2:54 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 03-Nov-21 | Grant | 7,787 | $0.72 | $5,591.07 | 30% 26.29K to 34.07K | |
| 05-Nov-21 2:58 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 03-Nov-21 | Grant | 7,939 | $0.72 | $5,700.20 | 8% 102.25K to 110.19K | |
| 17-Aug-21 4:08 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 17-Aug-21 | Market Purchase | 4,000 | $0.90 | $3,582.00 | 2% 198.49K to 202.49K | (11%) |
| 05-May-21 5:11 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 03-May-21 | Grant | 9,563 | $0.57 | $5,422.22 | 57% 16.72K to 26.29K | |
| 05-May-21 5:10 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 03-May-21 | Grant | 9,822 | $0.57 | $5,569.07 | 11% 86.42K to 96.25K | |
| 05-Nov-20 5:44 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 03-Nov-20 | Grant | 4,879 | $0.56 | $2,737.12 | 6% 81.55K to 86.42K | 14% |
| 05-Nov-20 5:42 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 03-Nov-20 | Grant | 4,723 | $0.56 | $2,649.60 | 39% 12.0K to 16.72K | 14% |
| 24-Aug-20 8:08 AM View: | Hanish Arnold C Director | Flex Pharma, Inc. (SLRX) | 21-Aug-20 | Market Purchase | 4,000 | $0.98 | $3,920.00 | 54% 7.35K to 11.35K | (17%) |
| 20-Aug-20 7:59 AM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 19-Aug-20 | Market Purchase | 2,000 | $1.01 | $2,020.00 | 200% 1.0K to 3.0K | (20%) |
| 18-Aug-20 8:35 AM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 17-Aug-20 | Market Purchase | 5,000 | $1.00 | $5,000.00 | 71% 7.0K to 12.0K | (19%) |
| 20-Feb-20 4:07 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 19-Feb-20 | Market Purchase | 2,000 | $0.95 | $1,900.00 | 40% 5.0K to 7.0K | (16%) |
| 18-Feb-20 4:48 PM View: | Jordan Scott Chief Business Officer | Flex Pharma, Inc. (SLRX) | 18-Feb-20 | Market Purchase | 11,300 | $0.90 | $10,170.00 | 56% 20.31K to 31.61K | (12%) |
| 13-Feb-20 5:57 PM View: | Rosenblum Mark J Exec VP Finance, CFO | Flex Pharma, Inc. (SLRX) | 13-Feb-20 | Market Purchase | 5,000 | $0.86 | $4,295.00 | 100% 0 to 5.0K | (8%) |
| 12-Feb-20 9:32 PM View: | Arthur David J. Chief Executive Officer Director | Flex Pharma, Inc. (SLRX) | 11-Feb-20 | Purchase | 2,175 | $1.15 | $2,501.25 | 3% 79.37K to 81.55K | |
| 12-Feb-20 9:33 PM View: | McCreedy Bruce J Jr. Director | Flex Pharma, Inc. (SLRX) | 11-Feb-20 | Purchase | 8,700 | $1.15 | $10,005.00 | 100% 0 to 8.7K | |
| 12-Feb-20 9:36 PM View: | McVicar William K. Director | Flex Pharma, Inc. (SLRX) | 11-Feb-20 | Purchase | 8,700 | $1.15 | $10,005.00 | 100% 0 to 8.7K | |
| 12-Feb-20 9:33 PM View: | Hanish Arnold C Director | Flex Pharma, Inc. (SLRX) | 11-Feb-20 | Purchase | 4,350 | $1.15 | $5,002.50 | 145% 3.0K to 7.35K | |
| 12-Feb-20 9:34 PM View: | Burleson Tess Director | Flex Pharma, Inc. (SLRX) | 11-Feb-20 | Purchase | 4,350 | $1.15 | $5,002.50 | 100% 0 to 4.35K | |
| 12-Feb-20 9:34 PM View: | Northrup Jonathan P Director | Flex Pharma, Inc. (SLRX) | 11-Feb-20 | Purchase | 8,700 | $1.15 | $10,005.00 | 3% 344.01K to 352.71K | |
| 26-Nov-19 8:47 AM View: | Hanish Arnold C Director | Flex Pharma, Inc. (SLRX) | 25-Nov-19 | Market Purchase | 3,000 | $3.59 | $10,770.00 | 100% 3.0K to 6.0K | (78%) |
| 05-Feb-19 10:00 PM View: | Boston Foundation, Inc. 10% Owner | Flex Pharma, Inc. (SLRX) | 30-Jan-19 | Market Sale | 1,600,000 | $0.33 | $521,600.00 | (42%) 3.8M to 2.2M | 90% |
| 10-Jan-19 9:48 AM View: | Boston Foundation, Inc. 10% Owner | Flex Pharma, Inc. (SLRX) | 09-Jan-19 | Market Sale | 337,000 | $0.37 | $123,848.00 | (17%) 1.94M to 1.6M | 91% |
| 09-Jan-19 11:26 AM View: | Boston Foundation, Inc. 10% Owner | Flex Pharma, Inc. (SLRX) | 08-Jan-19 | Market Sale | 263,000 | $0.40 | $104,306.00 | (12%) 2.2M to 1.94M | 92% |
| 21-Dec-18 10:00 PM View: | Westphal Christoph H 10% Owner | Flex Pharma, Inc. (SLRX) | 20-Dec-18 | Gift | 2,200,000 | -- | -- | (71%) 3.08M to 882.82K | |
| 21-Dec-18 10:00 PM View: | Westphal Christoph H 10% Owner | Flex Pharma, Inc. (SLRX) | 06-Nov-18 | Gift | 858,300 | -- | -- | (22%) 3.94M to 3.08M | |
| 18-Oct-18 5:03 PM View: | Longwood Fund Ii, L.P. 10% Owner | Flex Pharma, Inc. (SLRX) | 16-Oct-18 | Market Sale | 3,212,860 | $0.92 | $2,941,050.00 | (100%) 3.21M to 0 | 97% |
| 18-Oct-18 5:02 PM View: | Westphal Christoph H 10% Owner | Flex Pharma, Inc. (SLRX) | 16-Oct-18 | Market Sale Duplicate | 3,212,860 | $0.92 | $2,941,050.00 | (45%) 7.15M to 3.94M | 97% |
| 08-Nov-16 4:23 PM View: | Westphal Christoph H President and CEO Director 10% Owner | Flex Pharma, Inc. (SLRX) | 08-Nov-16 | Market Purchase | 7,000 | $7.31 | $51,170.00 | < 1% 7.15M to 7.15M | (100%) |
